TGFB1 and inflammation: Viable, impaired TGF-β antiproliferative effect on T cells, spontaneous chronic intestinal inflammation, and immune function defects leading to death between 1 and 8 months. In LckCre-Smad2f/f, severe autoimmunity and inflammation, death within 3 to 5 weeks of age